Skip to main content
FEE.org
  • For Students
    • Hazlitt Fellowship
    • Hackathon
    • Seminars
  • For Teachers
  • Analysis & Opinion
  • Shows
  • About
  • Store
  • Donate

Pharmaceuticals

Economics

Rare Diseases May Be Unprofitable to Treat, but That Doesn’t Mean Government Intervention Will Help

January 10, 2024 | Walter Block
Politics

Could Mark Cuban’s Plan to Disrupt Big Pharma Actually Work?

February 9, 2022 | Hannah Cox
Economics

Why Price Controls Will Result in Fewer Life-Saving Drugs

October 8, 2020 | Daniel J. Mitchell
Economics

Price Controls Aren’t the Answer on Pharmaceuticals

June 12, 2019 | Ross A. Marchand
Economics

A Government Guide to Keeping Insulin Unaffordable: 3 Easy Steps to Hogtie a Market

March 25, 2019 | Laura Williams
Economics

FDA Approves Record Number of Generic Drugs in 2018

January 10, 2019 | Raymond J. March
Economics

Elizabeth Warren Introduces Legislation to Create a Government-Run Pharmaceutical Manufacturer

December 20, 2018 | Molly Prince
Economics

EpiPen Pricing Controversy Reveals Ignorance about Market Competition

June 26, 2018 | Raymond J. March
Economics

Dr. Ron Paul: Unleash the Market to Lower Drug Prices

March 13, 2018 | Ron Paul, M.D.
Economics

Entrepreneurship Can Succeed Where Politics Fails

October 25, 2017 | Jairaj Devadiga
FEE.org

General

  • Contact
  • Careers and Internships
  • Annual Reports
  • Financial Data
  • Privacy Policy

Commentary

  • Newsletters
  • Write For Us
  • eBooks
  • Freeman Archives

Students & Educators

  • Education Entrepreneurship Lab
  • LiberatED
  • Get Involved: Opportunities
  • RSS Feed

  • For Students
    • Hazlitt Fellowship
    • Hackathon
    • Seminars
  • For Teachers
  • Analysis & Opinion
  • Shows
  • About
  • Store
  • Donate